Pancolitis and genetic markers in the Spanish population

Revista Espanola de Enfermedades Digestivas

Volumn 91, Issue 4, 1999, Pages 273-276

  Fernández Arquero, Miguel ^a   Lopez Nava G ^a   Garcia Paredes J ^a   Martinez A ^a   De la Concha, E G ^a   Figueredo, M A ^a   Conejero, L ^a   Vigil, P ^a   Diaz Rubio M ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Class II genes; Ulcerative colitis

Indexed keywords

ADULT; ARTICLE; FEMALE; GENETIC MARKER; GENETICS; HUMAN; MALE; SPAIN; ULCERATIVE COLITIS;

ADULT; COLITIS, ULCERATIVE; FEMALE; GENETIC MARKERS; HUMANS; MALE; SPAIN;

EID: 0033109055     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Monsén U, Boströ O, Nordenvall B, Sörstad J, Hellers G. Prevalence of inflammatory bowel disease among relatives of patients with ulcerative colitis. Scand J Gastroenterol 1987;22:214-8.
2. McConnell RB, Vadheim CM. Inflammatory bowel disease. In: King RA, Rotter JI, Motulsky AO, eds. The genetic basis of comon diseases. Oxford: Oxford University; 1992. p. 326-48.
3. Probert CS, Jayanthy V, Hughes AO, Thompso JR, Wicks AC, Mayberry JF. Prevalence and family risk of ulcerative colitis and Crohn's disease: epidemiological study among Europeans and South Asians in Leicesterhire. Gut 1993;34: 1547-51.
4. Tysk C, Lindberg E, Jarnerot G, Flodereus-Myrhed B. Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of hereditability and the influence of smoking. Gut 1988;29:990-6.
5. Satsangi J, Jewell DP, Rosenberg WMC, Bell JI. Genetics of inflammatory disease. Gut 1994;35:696-700.
6. Sugimura K, Asakura H, Mizuki N, Inoue M, Hibi T, Yagita A, et al. Analysis of genes within the HLA region affecting susceptibility to ulcerative colitis. Hum Immunol 1993;36: 112-8.
7. Futami S, Aoyama N, Honsako Y, Tamura T, Morimoto S, Nakashima T, et al. HLA-DRB1*1502 allele, subtype of DR15, is associated with susceptibility to ulcerative colitis and its progression. Dig Dis Sci 1995;40:814-8.
8. De la Concha EG, Fernández-Arquero M, Santa Cruz S, López Nava G, Figueredo MA, Díaz Rubio M, et al. Positive and negative associations of distinct HLA-DR2 subtypes with ulcerative colitis (UC). Clin Exp Immunol 1997;108: 392-5.
9. Toyoda H, Wang S-J, Yang H-Y, Redford A, Magalong D, Tyan D, et al. Distinct associations of HLA class II genes with inflammatory bowel disease. Gastroenterology 1993; 104:741-8.
10. Duerr RH, Neigut DA. Molecularly defined HLA-DR2 alleles in ulcerative colitis and an antineutrophil cytoplasmic antibody-positive subgroup. Gastroenterology 1995; 108:423-7.
11. Satsangi J, Welsh KI, Bunce M, Julier C, Farrant JM, Bell JI, et al. Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease. Lancet 1996;347:1212-7.
12. Naom I, Lee J, Ford D, Bowman SJ, Lanchbury JS, Haris I, et al. Analysis of the contribution of HLA genes to genetic predisposition in inflammatory bowel disease. Am J Hum Genet 1996;59:226-33.
13. Roussomoustakaki M, Satsangi J, Welsh K, Louis E, Fanning G, Targan S, et al. Genetic markers may predict disease behavior in patients with ulcerative colitis. Gastroenterology 1997;112:1845-53.
14. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol 1989;Supl 170(24):2-6.
15. Miller S, Dykes D, Polesky H. A salting-out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
16. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, et al. Primer-directed amplification of DNA with a thermostable DNA polymerase. Science 1988;239:487-91.
17. Kimura A, Sasazuki T. Eleventh international Histocompatibility workshop reference protocol for the HLA DNA-typing technique. In: Tsuji K, Aizawa M, Sasazuki T, eds. HLA 1991. Proceedings of the eleventh international histocompatibility workshop and conference. Oxford: Oxford University Press; 1991. p. 397-419.
18. She J-X. Susceptibility to type I diabetes: HLA-DQ and DR revisited. Immunol Today 1996;17:323-9.